Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
We compare which high yield ETF is tax efficient for retirement, highlighting tax considerations, holdings, and strategies to maximize after-tax income.
26,922 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Today, bitcoin rips past $82,000 as oil prices slump on de-escalation headlines, fueling a wave of short-covering and...
New Hampshire lawmakers pivot from a sweeping pro-housing mandate to targeted reforms after local pushback. HB1010 mo...
Home builders are embedding smart security: builder technology at scale, driving real-time monitoring, interoperabili...
A new Girl Scouts survey reveals AI is now a regular companion for girls ages 5-13, often seen as a smarter tutor and...
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
This deep-dive breaks down senestech snes 2026 earnings for Q1, translating the numbers into practical signals for in...
A global CEO survey shows a shift away from junior roles as companies deploy AI. The move, echoed by Harvard findings...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...
A potential agreement with Iran could unlock sanctions relief, release frozen assets, and reopen Gulf shipping. Negot...
REMAX Select reports a sharp rise in transaction sides driven by collaboration across markets, earning a top-10 place...